GlaxoSmithKline Pharmaceuticals Share Price
₹2,231.10 +30 (1.36%)
08 Jan, 2025 03:26
Start SIP in GLAXO
Start SIPPerformance
- Low
- ₹2,189
- High
- ₹2,240
- 52 Week Low
- ₹1,842
- 52 Week High
- ₹3,088
- Open Price₹2,232
- Previous Close₹2,201
- Volume96,662
Investment Returns
- Over 1 Month -4.78%
- Over 3 Month -18.91%
- Over 6 Month -12.12%
- Over 1 Year + 3.79%
Smart Investing Starts Here Start SIP with GlaxoSmithKline Pharmaceuticals for Steady Growth!
GlaxoSmithKline Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 56
- PEG Ratio
- 13.3
- Market Cap Cr
- 37,796
- P/B Ratio
- 22.6
- Average True Range
- 63.65
- EPS
- 47.33
- Dividend Yield
- 2
- MACD Signal
- -56.17
- RSI
- 41.69
- MFI
- 49.7
GlaxoSmithKline Pharmaceuticals Financials
GlaxoSmithKline Pharmaceuticals Technicals
EMA & SMA
Current Price
₹2,231.10
+
30
(1.36%)
- Bullish Moving Average 2
- Bearish Moving Average 14
- 20 Day
- ₹2,274.04
- 50 Day
- ₹2,384.90
- 100 Day
- ₹2,467.57
- 200 Day
- ₹2,408.74
Resistance and Support
2219.93
- R3 2,302.17
- R2 2,271.03
- R1 2,251.07
- S1 2,199.97
- S2 2,168.83
- S3 2,148.87
GlaxoSmithKline Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
GlaxoSmithKline Pharmaceuticals F&O
About GlaxoSmithKline Pharmaceuticals
- NSE Symbol
- GLAXO
- BSE Symbol
- 500660
- Managing Director
- Mr. B Akshikar
- ISIN
- INE159A01016
Similar Stocks to GlaxoSmithKline Pharmaceuticals
GlaxoSmithKline Pharmaceuticals FAQs
GlaxoSmithKline Pharmaceuticals share price is ₹2,231 As on 08 January, 2025 | 03:12
The Market Cap of GlaxoSmithKline Pharmaceuticals is ₹37796.2 Cr As on 08 January, 2025 | 03:12
The P/E ratio of GlaxoSmithKline Pharmaceuticals is 56 As on 08 January, 2025 | 03:12
The PB ratio of GlaxoSmithKline Pharmaceuticals is 22.6 As on 08 January, 2025 | 03:12
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.